(by David McLoone | LifeSite News) – The U.S. Food and Drug Administration (FDA) approved the mRNA Pfizer COVID jab booster for use in teenagers aged 16 and 17 Thursday. In its authorization, the FDA sidestepped consulting its Vaccines and Related Biological Products Advisory Committee (VRBPAC), an independent body of vaccine advisors, admitting in its December 9 press release that the FDA purposely did not meet with the committee. “[The] agency previously convened the committee for extensive discussions regarding the use of booster doses of COVID-19 vaccines and, after review of Pfizer’s EUA [emergency use authorization] request, the FDA concluded that the request does […]

This post was originally published on this site